BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2003) 76, 659-661
© 2003 British Institute of Radiology
doi: 10.1259/bjr/12708512

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cappabianca, S
Right arrow Articles by Galizia, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cappabianca, S
Right arrow Articles by Galizia, G

Case report

Myxopapillary ependymoma of the ischioanal fossa

S Cappabianca, MD 1 A Barberi, MD 1 R Grassi, MD 1 E Lieto, MD 2 F Fulciniti, MD 3 and G Galizia, MD 2

1 Sezione Scientifica di Diagnostica per immagini, Radioterapia e Medicina Nucleare, 2 Dipartimento di Chirurgia Generale ed Endoscopica and 3 Università degli Studi "Federico II" di Napoli, Dipartimento di Scienze Biomorfologiche e Funzionali, Istituto di Anatomia Patologica

Correspondence: Dr Salvatore Cappabianca, Viale Farnese, 36, 80131-Napoli, Italy


    Abstract
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
Ependymomas outside the confines of the cranium and spinal cord are rare. Direct extension into the soft tissues of the sacrococcygeal area may occur from a primary ependymoma of the spinal cord, cauda equina or filum terminale. Alternatively they may occur as a primary pre-sacral, pelvic and abdominal tumour, or as a primary tumour of the skin and subcutaneous tissue of the sacrococcygeal area without any demonstrable connection with the spinal cord. The Authors report a case of myxopapillary ependymoma of the ischioanal fossa, demonstrated by MRI. To our knowledge, our case is the first lesion reported at this site.


    Introduction
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
Ependymomas account for 60% of glial spinal cord tumours overall, but comprise 90% of primary tumours of the filum terminale and cauda equina; at this site the majority of ependymomas (30–80%) are of the myxopapillary subtype [14].

Ependymomas outside the confines of the cranium and spinal cord are rare. Direct extension into the soft tissues of the sacrococcygeal area may occur from a primary ependymoma of the spinal cord, cauda equina or filum terminale [5]. Alternatively they may occur as a primary pre-sacral, pelvic or abdominal tumour, or as a primary tumour of the skin and subcutaneous tissue of the sacrococcygeal area without any demonstrable connection with the spinal cord [69].

On the other hand, extraspinal ependymomas present in two characteristic locations: in the soft tissue posterior to the sacrum or in the pelvis, and in the retro-rectal space anterior to the sacrum [6].

The Authors report a case of a myxopapillary ependymoma in the ischioanal fossa, demonstrated by MRI. To our knowledge, our case is the first lesion reported at this site.


    Case report
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
A previously healthy 61-year-old male presented with a 3-month history of rectal tenesmus and constipation. Rectal examination revealed a rectum reduced in lumen by extrinsic compression palpable on the right aspect of the rectal wall approximately 2 cm above the anus. Sigmoidoscopy showed no mucosal abnormalities.

There were no abnormalities on neurological examination.

The patient underwent an MR examination with a 1.0 T superconductive scanner (Magnetom SP 42 E; Siemens, Erlangen, Germany); spin-echo T1 weighted images in all orthogonal planes (repetition time (TR)=450, echo time (TE)=10) before and after intravenous administration of gadolinium (0.1 mmol kg-1 of Gd-DTPA – Magnevist, Schering) and axial spin-echo DP-T2 weighted sequences (TR=2000, TE=13/80) were obtained. A soft-tissue mass located in the right ischioanal fossa, closely related to the anal canal wall, was demonstrated; it was sharply defined, of hypo-isointense signal intensity on T1 weighted images, and with inhomogeneous moderate increased signal on T2 weighted images (Figures 1 and 2GoGo). After intravenous administration of gadolinium, the lesion showed highly inhomogeneous enhancement, characterized by a low signal intensity peripheral rim, with central focal nodules of marked enhancement. No enhancing strands extending across the mass were demonstrable (Figure 3Go). There were no other abnormalities.



View larger version (137K):
[in this window]
[in a new window]
 
Figure 1. Sagittal MR T1 weighted image. Evidence of irregularly lobulated mass located in the right ischioanal fossa. The mass (arrows) shows hypo-isointense signal intensity.

 


View larger version (90K):
[in this window]
[in a new window]
 
Figure 2. Axial MR T2 weighted image. The lesion (arrows) shows inhomogeneously high signal intensity, with surrounding band of low signal intensity.

 


View larger version (93K):
[in this window]
[in a new window]
 
Figure 3. Axial MR T1 weighted image after intravenous administration of contrast medium. Evidence of contrast enhancement in central region of the lesion with peripheral rim of unenhancing tissue.

 
No abnormality was found on chest CT and hepatic ultrasound.

Surgical removal of the mass was performed; no connection was found between the mass and the filum terminale. Pathology with immunohistochemical staining revealed a papillary group of cubic to cylindrical cells immersed in a loose metachromatic myxoid stroma, with psammomatous calcifications. The neoplastic cells were arranged in papillary groups in an epithelial-like fashion with respect to some spindle cells in the core of the papillary group.

The diagnosis of myxopapillary ependymoma was made.


    Discussion
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 
Ependymomas are relatively uncommon neoplasms, comprising about 5% of all neurogenic tumours [10], accounting for 60% of glial spinal cord tumours overall, but comprise 90% of primary tumours in the filum terminale and cauda equina, whilst brain localizations are rare. They arise from ependymal cells lining the central canal or its remnants, and from cells of the ventriculus terminalis in the filum terminale. Intramedullary lesions are typically cellular ependymomas and tend to occur in the cervical tract of spinal cord. The most common site for ependymomas is the conus medullaris and filum terminale, with a peak incidence in the fourth decade. At this site, most tumours are of the myxopapillary subtype [13].

The appellation "myxopapillary" is based on the tendency of this ependymoma to produce mucin and form papillae by virtue of its arborizing vasculature, replacing the architecture of the normal filum terminale [9]. Myxopapillary ependymoma, a low grade glioma, is characterized by distinctively abundant supporting fibrous connective stroma, with foci of mucinous degeneration and mucin secretation by tumour cells [3, 4].

Ependymomas are rare outside the central nervous system and may be found in four general situations: metastatic extension from a primary central nervous system neoplasm; direct extension into the soft tissue of the sacrococcygeal area from primary ependymoma of the spinal cord, filum terminale or cauda equina [5]; primary tumour of the skin and subcutaneous tissue without any demonstrable connection with the spinal cord [2, 8, 9]; primary presacral, pelvic or abdominal tumour [6].

Our case fell into the latter category of primary pelvic myxopapillary ependymoma.

Ectopic ependymomas have also been reported in the mediastinum, uterosacral ligament, ovary and lung [1114].

The origin of extraspinal ependymomas has been attributed to the coccygeal medullary vestige, an ependymal cell-lined cavity, that is a remnant of the caudal portion of the neural tube, which is located beneath the skin of the post-natal pit, over the tip of the coccyx [8, 15]. These vestiges are a common finding in infants and childhood (median age 17 years) and may evolve with malignant degeneration, but usually involute or regress [8, 16]. Nevertheless, ependymal cells may be found within the coccygeal ligament as well as in heterotopic positions, and it is therefore not surprising that ependymomas may rarely occur in extraspinal locations and particularly in the soft tissue posteriorly to the sacrum or in the pelvis in the retro-rectal space [6].

Myxopapillary ependymomas clinically appear to be slowly progressive tumours [3, 9, 16]. The clinical presentation depends on the location: patients, whose tumour is pelvic, present predominantly with a palpable mass at pelvic and/or rectal examination, often associated with bowel and bladder dysfunction and in many cases, with symptoms of sacral nerve root involvement, as loss of the ankle jerk and/or decreased rectal sphincter tone [6].

Prognosis appears not to be related to mitotic activity, cytological features, extensive mucinous change and hyalinization [3]. Systemic metastases of myxopapillary ependymomas, especially in extraspinal locations, have been documented [3, 5, 6, 1618]. Helwig and Stern, in their series of 32 subcutaneous sacrococcygeal myxopapillary ependymomas, reported an incidence of 17%, the majority of which occurred in the lung and inguinal lymph nodes [6, 8, 16, 18, 19]. Other reported sites are the vertex of the skull and vertebral bodies [16, 20].

The imaging features of ependymoma developing outside the central nervous system have not been extensively reported; however, the features on CT and MRI are similar to those of ependymomas in the spinal canal [2, 21].

Contrast enhanced CT demonstrates a mass of soft tissue density which enhances after intravenous contrast administration [2]. T1 weighted on MRI sequences demonstrate low-intermediate homogeneous signal intensity within the mass; which post intravenous gadolinium administration, shows focal nodules of enhancement peripherally with strands of enhancement extending across the mass, or intense homogeneous enhancement. T2 weighted images on MRI show high signal, slightly lower than adipose tissue, within well circumscribed mass. The mass frequently has a peripheral rim of low signal due to the local deposition of hemosiderin. Focal necrosis, cystic degeneration and/or haemorrhage may result in an inhomogeneous lesion with mixed signal intensity [2, 21].

The differential diagnosis of a pelvic myxopapillary ependymoma includes inflammatory diseases (perirectal abscesses; internal fistulas), congenital tumours (chordomas; teratomas; dermoids), other neurogenic (neurofibroma) and osseous neoplasms or miscellaneous lesions as well as anterior meningoceles and metastatic tumours.

To our knowledge, this case is the first reported one of myxopapillary ependymoma of the ischioanal fossa in an adult patient.

Received for publication March 9, 2002. Revision received October 24, 2002. Accepted for publication January 10, 2003.


    References
 Top
 Abstract
 Introduction
 Case report
 Discussion
 References
 

  1. Kernohan JW. Primary tumours of the spinal cord and intradural filum terminale. In: Penfield W, editor. Cytology and cellular pathology of the nervous system, Vol 3. New York: Paul B. Hoeber, 1932:993–1025.
  2. Grubnic S, MacVicar D. A perianal problem. Br J Radiol 1999;72:1235–6.[Medline]
  3. Sonneland PRL, Scheithauer BW, Onofrio BM. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer 1985;56:883–93.[CrossRef][Medline]
  4. Russell DS, Rubenstein LJ. Tumours of central neuroeithelial origin. In: Pathology of tumours of the nervous system (5th edn). Baltimore: Williams & Wilkins, 1989:83–350.
  5. Anderson MS. Myxopapillary ependymomas presenting in the soft tissue over the coccygeal region. Cancer 1966;19:585–90.[CrossRef][Medline]
  6. Morantz RA, Kepes JJ, Ratnitzky S, Masterson BJ. Extraspinal ependymomas. J Neurosurg 1979;51:383–91.[Medline]
  7. Domingues RC, Mikulis D, Swearingen B, Tompkins R, Rosen BR. Subcutaneous sacrococcygeal myxopapillary ependymoma: CT and MR findings. Am J Neuroradiol 1991;12:171–2.[Medline]
  8. Helwig EB, Stern JB. Subcutaneous coccygeal myxopapillary ependymoma. A clinico-pathological study of 32 cases. Am J Clin Pathol 1984;81:156–61.[Medline]
  9. Kumar ND, Misra K. Fine needle aspiration cytodiagnosis of subcutaneous sacrococcygeal myxopapillary ependymoma. A case report. Acta Cytol 1990;34:851–4.[Medline]
  10. Zulch KJ. Brain tumours, their biology and pathology. (3rd edn). Berlin: Springer Verlag, 1986:260.
  11. Nobles E, Russel L, Kiercher T. Mediastinal ependymoma. Hum Pathol 1991;22:94–6.[CrossRef][Medline]
  12. Duggan MA, Hugh J, Nation JG, Robertson DI, Stuart GC. Ependymoma of the uterosacral ligament. Cancer 1989;64:2565–71.[CrossRef][Medline]
  13. Carr KA, Roberts JA, Francks TS. Progesterone receptors in bilateral ovarian ependymoma presenting in pregnancy. Hum Pathol 1992;23:962–5.[CrossRef][Medline]
  14. Crotty T, Hooker RP, Swensen S, Scheithauser BW, Myers JL. Primary malignant ependymoma of the lung. Mayo Clin Proc 1992;67:373–8.[Medline]
  15. Wolff M, Santiago H, Duby MM. Delayed distant metastasis from a subcutaneous sacrococcygeal myxopapillary ependymoma: case report with tissue culture, ultrastructural observations and review of literature. Cancer 1972;30:1046–67.[CrossRef][Medline]
  16. Saint Martin GA, Aranha GV, Castelli MJ, Gattuso P. Fine-needle aspiration diagnosis of metastasic anaplastic sacrococcygeal ependymoma to the lungs. Diagn Cytopathol 1996;15:228–30.[CrossRef][Medline]
  17. Mavroudis C, Townsend JJ, Wilson CB. A metastasising ependymoma of the cauda equina: case report. J Neurosurg 1977;47:775.
  18. Bardales RH, Porter MC, Sawyer JR, Mrak RE, Stanley MW. Metastatic myxopapillary ependymoma: report of a case with fine-needle aspiration findings. Diagn Cytopathol 1994;10:47–53.[Medline]
  19. Vagaiwala MR, Robinson JS, Galicich JH, Gralla FJ, Helson RJ, Besttie EV. Metastasizing extradural ependymoma of the sacrococcygeal region, case report and review of the literature. Cancer 1979;44:326–33.[CrossRef][Medline]
  20. Mirabell R, Louis D, O’Keeffe D, Rosemberg A, Suit H. Metastatic ependymoma of the sacrum. Cancer 1990;65:2353–5.[CrossRef][Medline]
  21. Yamada CY, Whitman GJ, Chew FS. Myxopapillary ependymoma of the filum terminale. AJR Am J Roentgenol 1997;168:366.[Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cappabianca, S
Right arrow Articles by Galizia, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cappabianca, S
Right arrow Articles by Galizia, G


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS